Search Within

David Hyman

  1. "Elsevier Inc."
Formats
  1. Meeting Abstract (10)
  2. Journal Article (2)
  3. Review (1)
Groups
  1. Department of Medicine (13)
  2. Early Drug Development Service (13)
  3. Solid Tumor Oncology Division (13)
  4. Thoracic Oncology (6)
  5. GSK Faculty (4)
  6. Human Oncology and Pathogenesis Program (4)

More Groups

People
  1. Alexander Drilon (6)
  2. Bob Li (2)
  3. Charles Rudin (2)
  4. Gregory Riely (2)
  5. Jose Baselga (2)
  6. Marc Ladanyi (2)

More People

Years
  1. 2021 (1)
  2. 2020 (1)
  3. 2019 (3)
  4. 2018 (2)
  5. 2016 (2)
  6. 2015 (3)

More Years

Publications
  1. Journal of Thoracic Oncology (6)
  2. European Journal of Cancer (4)
  3. Cancer Treatment Reviews (1)
  4. Clinical Lymphoma, Myeloma and Leukemia (1)
  5. Drug Discovery Today (1)
Publishers
  1. Elsevier Inc. (13)

Results (13)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 2 study of erdafitinib in patients with advanced solid tumors and fibroblast growth factor receptor gene alterations
    Meeting Abstract

    Pant, S.; Tabernero, J.; Massard, C.; Hyman, D. M.; Witt, O.; Doi, T.; Qin, S.; Lu-Emerson, C.; Hargrave, D.; Garcia-Corbacho, J.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Activity of larotrectinib in tropomyosin receptor kinase fusion lung cancer
    Meeting Abstract

    Farago, A. F.; Kummar, S.; Moreno, V.; Patel, J.; Lassen, U.; Rosen, L.; Childs, B. H.; Hyman, D. M.; Drilon, A.
    Journal of Thoracic Oncology (2020)

    Fulltext@MSK | Save
  • Molecular characteristics, immunophenotype, and immune checkpoint inhibitor response in BRAF non-V600 mutant lung cancers
    Meeting Abstract

    Offin, M.; Pak, T.; Mondaca, S.; Montecalvo, J.; Rekhtman, N.; Halpenny, D.; Wu, S.; Kris, M.; Paik, P.; Riely, G.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Activity of larotrectinib in TRK fusion lung cancer
    Meeting Abstract

    Farago, A.; Kummar, S.; Moreno, V.; Patel, J.; Lassen, U.; Rosen, L.; Ku, N.; Cox, M.; Nanda, S.; Childs, B.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Improving attribution of adverse events in oncology clinical trials
    Review

    George, G. C.; Barata, P. C.; Campbell, A.; Chen, A.; Cortes, J. E.; Hyman, D. M.; Jones, L.; Karagiannis, T.; Klaar, S.; Le-Rademacher, J. G.; more...
    Cancer Treatment Reviews (2019)

    Fulltext@MSK | Save
  • Utilization, safety, and efficacy of the FDA compassionate use program
    Meeting Abstract

    Feit, N.; Smith, E.; Cambria, R.; Anopa, J.; Deighan, J.; Pamer, E.; Wilson, R.; Greenfield, J.; Zivanovic, O.; Hyman, D.
    European Journal of Cancer (2018)

    Fulltext@MSK | Save
  • Preliminary clinical activity of repotrectinib (TPX-0005) in advanced ROS1 fusion-positive non-small cell lung cancer
    Meeting Abstract

    Ou, S.; Cho, B. C.; Kim, D.; Drilon, A.; Lee, J.; Lin, J.; Zhu, V.; Ahn, M.; Camidge, D. R.; Shanna Stopatschinskaja, S.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Dose- and regimen-finding phase I study of NVP-HDM201 in patients (pts) with TP53 wild-type (wt) advanced tumors
    Meeting Abstract

    Hyman, D.; Chatterjee, M.; Langenberg, M. H. G.; Lin, C. C.; Suarez, C.; Tai, D.; Cassier, P.; Yamamoto, N.; De Weger, V. A.; Jeay, S.; more...
    European Journal of Cancer (2016)

    Fulltext@MSK | Save
  • Neratinib induces estrogen receptor function and sensitizes HER2-mutant breast cancer to anti-endocrine therapy
    Meeting Abstract

    Scaltriti, M.; Carmona, F. J.; Toska, E.; Cocco, E.; Hyman, D.; Cutler, R.; Avogadri-Connors, F.; Wick, M. J.; Papadopoulos, K. P.; Lalani, A. S.; more...
    European Journal of Cancer (2016)

    Fulltext@MSK | Save
  • Clinically adoption of MSK-IMPACT, a hybridization capture-based next generation sequencing assay, for the assessment of lung adenocarcinomas
    Meeting Abstract

    Arcila, M. E.; Zehir, A.; Yu, H.; Drilon, A.; Li, B. T.; Riely, G. J.; Rekhtman, N.; Lin, O.; Hyman, D.; Berger, M.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save